Read more about the new Center for Advanced Pediatrics.

Crafting a vaccine against respiratory syncytial virus (RSV) has been a minefield for 50 years, but scientists believe they have found the right balance. Researchers at Children’s Healthcare of...

Blood Blood (bloodjournal.org), the most cited peer-reviewed publication in the field of hematology, is available weekly in print and online. Blood is the official journal of the American Society of...

ATLANTA (Oct. 26, 2016) - Certain DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells, researchers from Winship Cancer Institute of...

ATLANTA (Oct. 10, 2016) – Biomedical engineers at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Emory University and Georgia...

A team of researchers from Emory, Children’s Healthcare of Atlanta and Georgia Tech showed in a paper, published in Nature Biotechnology, that scientists and researchers can improve protein-based drugs by reaching into the evolutionary past.

Doctors at Children’s are encouraging parents and professionals to learn a more improved form of swaddling, which includes leaving room at the bottom of the blanket for the infant’s hips and legs to move freely. This new initiative aims to reduce hip dysplasia in infants

A new compound has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the disease.

Leading national children’s hospitals, including Children's, along with pediatric cancer organizations and academic centers unite with Cancer MoonShot 2020. The consortium aims to accelerate bringing the next-generation standard of cancer care and immunotherapy to children with cancer.

The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta has been named a host institution for a collaborative international study sponsored by Novartis. This is a clinical trial analyzing the safety and effectiveness of an investigational cellular therapy treatment for children fighting cancer.